Cochrane Abstracts
Kinesthetic stimulation versus methylxanthine for apnea in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Kinesthetic Stimulation Versus Methylxanthine for Apnea in Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Kinesthetic_stimulation_versus_methylxanthine_for_apnea_in_preterm_infants.
Kinesthetic stimulation versus methylxanthine for apnea in preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Kinesthetic_stimulation_versus_methylxanthine_for_apnea_in_preterm_infants. Accessed March 17, 2025.
Kinesthetic stimulation versus methylxanthine for apnea in preterm infants. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Kinesthetic_stimulation_versus_methylxanthine_for_apnea_in_preterm_infants
Kinesthetic Stimulation Versus Methylxanthine for Apnea in Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Kinesthetic_stimulation_versus_methylxanthine_for_apnea_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Kinesthetic stimulation versus methylxanthine for apnea in preterm infants
ID - 439386
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Kinesthetic_stimulation_versus_methylxanthine_for_apnea_in_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
